Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients
Author:
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.12140/fullpdf
Reference47 articles.
1. [No authors listed]. Dacarbazine (DTIC) in malignant melanoma;Drug Ther Bull,1976
2. Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma;Luke;Clin Cancer Res,2012
3. BRAF in melanoma: pathogenesis, diagnosis, inhibition, and resistance;Sullivan;J Skin Cancer,2011
4. Distinct sets of genetic alterations in melanoma;Curtin;N Engl J Med,2005
5. Mutations of the BRAF gene in human cancer;Davies;Nature,2002
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular Susceptibility and Treatment Challenges in Melanoma;Cells;2024-08-20
2. Low incidence of BRAF and NRAS mutations in a population with a high incidence of melanoma;Virchows Archiv;2024-01-06
3. The Value of Histopathological Characteristics and BRAF and NRAS Mutations for the Diagnosis, Risk Stratification, and Prognosis of Malignant Invasive Melanoma;Melanoma - Standard of Care, Challenges, and Updates in Clinical Research;2023-04-05
4. Effects of BRAF V600E and NRAS mutational status on the progression‑free survival and clinicopathological characteristics of patients with melanoma;Oncology Letters;2022-11-24
5. The Genetics of Early-Stage Melanoma in a Veteran Population;Frontiers in Oncology;2022-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3